Perrigo has received final approval from the FDA for its abbreviated new drug application for over-the-counter famotidine 10mg, calcium carbonate 800mg, and magnesium hydroxide 165mg, chewable tablets.
Subscribe to our email newsletter
The product will be marketed under store brand labels and is comparable to Johnson & Johnson – Merck Consumer Pharmaceutical’s Pepcid Complete, an acid reducer plus antacid medication indicated for the relief of heartburn associated with acid indigestion and sour stomach. The company expects to begin shipping the product in the third quarter of calendar 2008.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.